Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Valvular Heart Disease

Free Subscription 23.02.2026 2 Ann Thorac Surg 2 Catheter Cardiovasc Interv 2 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 1 Circ Genom Precis Med 2 Circ Heart Fail 4 Eur Heart J 1 Eur J Cardiothorac Surg 1 Heart 2 J Am Coll Cardiol 1 J Thorac Cardiovasc Surg 1 Pediatr Cardiol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Thorac Surg

1. CHOI JW, Gaca J, Zwischenberger BA, Milano C, et al
   Survival after mechanical vs biological mitral valve replacement: Influence of age versus operative mortality score.
   Ann Thorac Surg. 2026 Feb 14:S0003-4975(26)00129.
   PubMed         Abstract available
   
   
2. BRAASCH MC, Kaneko T
   The Evolving Tsunami of Transcatheter Aortic Valve Replacement.
   Ann Thorac Surg. 2026 Feb 16:S0003-4975(26)00139.
   PubMed        
   
   

   
   Catheter Cardiovasc Interv

3. SORROPAGO A, De Marco F, Toscano E, Brambilla N, et al
   Assessment of the Safety and Effectiveness of the FLOWer Antiembolic Filter Supporting Transcatheter Aortic Valve Implantation.
   Catheter Cardiovasc Interv. 2026 Feb 18. doi: 10.1002/ccd.70524.
   PubMed         Abstract available
   
   
4. MANASRAH A, Khan F, Singh P, Yarkoni A, et al
   Post-Transcatheter Aortic Valve Replacement Acute Severe Mitral Regurgitation: A Case Report.
   Catheter Cardiovasc Interv. 2026 Feb 18. doi: 10.1002/ccd.70522.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

5. NKOMO VT, Tsai CM
   When Anatomy Meets Hemodynamics: Interpreting CTA Planimetry of Aortic Valve Area.
   Circ Cardiovasc Imaging. 2026 Feb 17:e019572.
   PubMed        
   
   
6. BAK M, Lee SY, Park SJ, Shin H, et al
   Left Atrial Strain Predicts Cardiac Outcomes in Moderate Aortic Stenosis.
   Circ Cardiovasc Imaging. 2026 Feb 20:e018451.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

7. EL-SABAWI B, Manandhar P, Butler J, Genereux P, et al
   Prediction of Heart Failure Hospitalization or Death After TAVR.
   Circ Cardiovasc Interv. 2025 Dec 31:e015398.
   PubMed         Abstract available
   
   
8. SINGH N, Cohen DJ, Chen S, Shah MA, et al
   Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights.
   Circ Cardiovasc Interv. 2026 Jan 2:e015441.
   PubMed         Abstract available
   
   

   
   Circ Genom Precis Med

9. BILEN O, Adler A, Bastiaenen R, MacNamara JP, et al
   Mavacamten Monotherapy in Real-World Patients With Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM.
   Circ Genom Precis Med. 2026;19:e005502.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

10. KASKI JP, Kantor PF, Nakano SJ, Olivotto I, et al
    Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.
    Circ Heart Fail. 2026;19:e013418.
    PubMed         Abstract available
    
    
11. LATUS H, Schindler V, Cleuziou J, Khalil M, et al
    Real-Time Biventricular Pressure-Volume Loops During Percutaneous Pulmonary Valve Implantation in Patients With RVOT Dysfunction.
    Circ Heart Fail. 2025 Dec 23:e013235. doi: 10.1161/CIRCHEARTFAILURE.125.013235.
    PubMed         Abstract available
    
    

    
    Eur Heart J

12. RAZAVI AC, Bhatia HS, Marrero N, Dzaye O, et al
    Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis.
    Eur Heart J. 2026 Feb 21:ehag018. doi: 10.1093.
    PubMed         Abstract available
    
    
13. MAZNYCZKA A, Pilgrim T, Philippon F, Rodes-Cabau J, et al
    Conduction disturbances after transcatheter aortic valve implantation.
    Eur Heart J. 2026 Feb 19:ehag093. doi: 10.1093.
    PubMed         Abstract available
    
    
14. LE RUZ R, Brener M, Rommel KP
    Acute haemodynamic instability after transcatheter tricuspid valve replacement: insights from pressure-volume loops.
    Eur Heart J. 2026 Feb 18:ehag031. doi: 10.1093.
    PubMed        
    
    
15. MARSAN NA, Bax JJ
    Transcatheter tricuspid valve replacement: defining the sweet spot for intervention.
    Eur Heart J. 2026 Feb 18:ehaf954. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Cardiothorac Surg

16. MEHAFFEY JH, Jagadeesan V, Bowdish M, Chauhan D, et al
    Young transcatheter aortic valve implantation: Shifting risk and outcomes.
    Eur J Cardiothorac Surg. 2026 Feb 18:ezag103. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

17. LOKESH N, Kannarkat JT, Reardon MJ
    Assessing transcatheter tricuspid valve replacement: evidence, viability and adoption.
    Heart. 2026 Feb 16:heartjnl-2025-327129. doi: 10.1136/heartjnl-2025-327129.
    PubMed        
    
    

    
    J Am Coll Cardiol

18. CHU MWA, Raymond S, Gelijns AC, Moskowitz AJ, et al
    Mitral Valve Repair for Degenerative MR With Moderate or Less Tricuspid Regurgitation: 2-Year Outcomes From a Multicenter Echocardiographic Core Laboratory-Adjudicated Cohort.
    J Am Coll Cardiol. 2026 Feb 18:S0735-1097(25)10598.
    PubMed         Abstract available
    
    
19. FORREST JK, Yakubov SJ, Deeb GM, Reardon MJ, et al
    Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    J Am Coll Cardiol. 2026 Feb 16:S0735-1097(26)05423.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

20. ZHU MZL, Konstantinov IE, Fricke TA, Konstantinov SI, et al
    Long-term Outcomes of Aortic Valve Repair in Children after Infancy.
    J Thorac Cardiovasc Surg. 2026 Feb 16:S0022-5223(26)00107.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

21. CNOTA JF, Chowdhury SM, Floh A, Gongwer R, et al
    Tricuspid Regurgitation and Impact of Surgical Valve Intervention in the Single Ventricle Reconstruction Trial.
    Pediatr Cardiol. 2026 Feb 18. doi: 10.1007/s00246-025-04122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum